EVO

Evotec SE

3.97 USD
-0.51 (-11.38%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Evotec SE stock is down -16.77% since 30 days ago. The next earnings date is Apr 24, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 33.33% of the previous 2 June’s closed higher than May.

About Evotec SE

Evotec SE operates as drug discovery and development partner for pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as diabetes and complications of diabetes, fibrosis, infectious diseases, CNS diseases, oncology, pain and inflammation, immunology, rare diseases, respiratory diseases, and women's health. It has collaboration agreements with Bayer AG; Lilly; Chinook Therapeutics; Novo Nordisk A/S; Galapagos; Pfizer Inc.; CONBA Pharmaceutical Co., Ltd.